GTI-2040: Preliminary Phase I/II data

Preliminary data from a dose-escalation Phase I/II trial, showed that GTI-2040 plus docetaxel as a second-line therapy led to disease stabilization in 10 out of 18 patients including 6 out of 10 at th...